USPTO 2015–2025 USPTO PatentsView US Corporation

Brain Tunnelgenix Technologies Corp.

USPTO PatentsView assignee record - 29 granted patents across 13 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Brain ranks #10,563 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 13 technology areas.

#10,563
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.4/100)
14.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R10563 · US Corporation #10,563 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 29 grants
  • UPPER-Q #10,563/49,997
  • PHOTO-FINISH Barclays Execution…
  • CPC-FOCUS A61B · 13 areas
  • INNOV-PAR 53.4/100
  • CLAIMS-RICH 14.8 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Barclays Execution Services Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Brain’s 53.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Brain

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Brain's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Brain?

Each dot is one of Brain’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Brain’s own 14.8 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Brain vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 28.92929.1 510152025 Granted patents (volume) Avg claims / patent Barclays Execution Services Limited - 29, 18.03Barclays Executio…Bear Robotics, Inc. - 29, 13.1Bear RoboticsBlue Force Gear, Inc. - 29, 14.07Blue Force GearBote, LLC - 29, 7BoteBritish Broadcasting Corporation - 29, 19.31British Broadcast…C.N.R.S. - 29, 13.83C N R SC3 Nano, Inc. - 29, 18.28C3 NanoC4 Therapeutics, Inc. - 29, 20.86C4 TherapeuticsBrain Tunnelgenix Technologies Corp. - 29, 14.76Brain Tunnelgenix
Brain vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Brain's grants concentrate

Brain Tunnelgenix Technologies Corp. is a focused PatentsView assignee: 13 CPC subclasses with 72.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (11 grants) versus a trough of 4 in 2022. By volume, Brain sits between Barclays Execution Services Limited and C4 Therapeutics, Inc..

Brain's three-year grant acceleration

Brain Tunnelgenix Technologies Corp. shows 20 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Brain's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Brain holds 29 patents at rank #10,564, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Brain

By rank, the assignees closest to #10,564 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Brain's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Brain, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Brain ranks #851 of 7,127 assignees by patent count in that subclass.

Brain's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

24681012 2022202320242025 9
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Brain Tunnelgenix Technologies Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 4 13.8%
2023 5 17.2%
2024 11 37.9%
2025partial year 9 31.0%

Which technologies does Brain Tunnelgenix Technologies Corp. patent most?

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Brain Tunnelgenix Technologies Corp.'s patent record in context - here's where to go next.

  • Brain Tunnelgenix Technologies Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 72.4% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #10,563 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Brain Tunnelgenix Technologies Corp. against Barclays Execution Services Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.